Lumexa Imaging (NASDAQ:LMRI) Shares Gap Up on Analyst Upgrade

Lumexa Imaging Holdings, Inc. (NASDAQ:LMRI)’s stock price gapped up before the market opened on Monday after Raymond James Financial upgraded the stock from an outperform rating to a strong-buy rating. The stock had previously closed at $10.80, but opened at $11.72. Raymond James Financial now has a $23.00 price target on the stock. Lumexa Imaging shares last traded at $11.63, with a volume of 116,667 shares trading hands.

Institutional Trading of Lumexa Imaging

A hedge fund recently bought a new stake in Lumexa Imaging stock. Geode Capital Management LLC acquired a new stake in shares of Lumexa Imaging Holdings, Inc. (NASDAQ:LMRI) in the fourth quarter, according to the company in its most recent Form 13F filing with the SEC. The fund acquired 83,675 shares of the company’s stock, valued at approximately $1,548,000. Geode Capital Management LLC owned 0.09% of Lumexa Imaging at the end of the most recent reporting period.

Lumexa Imaging Price Performance

About Lumexa Imaging

We are one of the largest national providers of diagnostic imaging services(1). Our platform is integrated, scalable and has a proven track record of creating value for our stakeholders. As of September 30, 2025, we and our affiliates operated the second largest(1) outpatient imaging center footprint in the United States. It spans 184 centers(2)across 13 states and includes eight joint venture partnerships with health systems. Our centers are in attractive metropolitan statistical areas (“MSAs”).